Fergal Delaney
About Fergal Delaney
Fergal Delaney serves as the Senior Licensing Manager at Aspect Biosystems in Vancouver, Canada, where he has worked since 2020. He has a background in business development and licensing, with previous roles at ERS Genomics and Kinesis Health Technologies, and holds advanced degrees in Biotechnology and Business from University College Dublin.
Work at Aspect Biosystems
Fergal Delaney has been serving as the Senior Licensing Manager at Aspect Biosystems since 2020. In this role, he is responsible for managing the company's patent portfolio, which is essential for the organization's growth and success. His expertise in licensing and business development supports Aspect Biosystems' strategic initiatives in the biotechnology sector. The company is based in Vancouver, British Columbia, Canada, and focuses on innovative bioprinting technologies.
Previous Experience in Business Development
Before joining Aspect Biosystems, Fergal Delaney worked as the Business Development & Licensing Manager for ERS Genomics in Dublin, Ireland, from 2018 to 2020. His role involved identifying and pursuing business opportunities in the genomics field. Prior to that, he held the position of Business Development Executive at Kinesis Health Technologies for 11 months in 2017-2018, where he contributed to the growth of the company through strategic initiatives.
Education and Expertise
Fergal Delaney holds a Master of Science in Biotechnology and Business from UCD Michael Smurfit Graduate Business School, which he completed in 2017. He also earned a Bachelor of Science in Genetics from University College Cork, where he studied various disciplines including biochemistry and computational biology from 2012 to 2016. His educational background provides a strong foundation for his work in biotechnology and business development.
Leadership Roles and Contributions
During his time at University College Cork, Fergal Delaney held leadership positions, including Membership Development Officer and Chairperson of the Genetics Society. He also served as the MSc class representative and Science Student Leader at UCD. These roles demonstrate his commitment to fostering community engagement and leadership within academic settings.
Thesis Project and Startup Collaboration
Fergal Delaney developed a four-year feasibility and business plan for Phision Therapeutics as part of his thesis project. This project included a pitch presentation for seed funding to experienced entrepreneurs and scientists. Additionally, he collaborated with startups and organizations such as Spira, the APC Microbiome Institute, and Teagasc during his undergraduate studies, gaining valuable experience in the biotechnology sector.